Methyl Chavicol and Its Synthetic Analogue as Possible Antioxidant and Antilipase Agents Based on the <i>In Vitro</i> and In Silico Assays

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Compound</td><td class="align_center">Binding affinity (kcal·mol<sup>−1</sup>)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">PLC</td><td class="align_center">−5.6</td></tr><tr><td class="align_left">Orlistat</td><td class="align_center">−6.5</td></tr><tr><td class="align_left">MC</td><td class="align_center">−6.1</td></tr><tr><td class="align_left">MPMO</td><td class="align_center">−6.1</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>PLC: diundecylphosphatidylcholine; MC: methyl chavicol; MPMO: 2-[(4-methoxyphenyl)methyl]oxirane.<br/></div></td></tr></table>

<div>Binding affinity between ligands and pancreatic lipase.</div>

Oxidative Medicine and Cellular Longevity

tab4

Table 4

Table 4: Methyl Chavicol and Its Synthetic Analogue as Possible Antioxidant and Antilipase Agents Based on the <i>In Vitro</i> and In Silico Assays 

Oxidative Medicine and Cellular Longevity

Methyl Chavicol and Its Synthetic Analogue as Possible Antioxidant and Antilipase Agents Based on the In Vitro and In Silico Assays

Table 4